Home › Trial NCT02772198
T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies
- Trial IDNCT02772198
- StatusUnknown
- PhasePhase 1/2
- Study typeInterventional
- SponsorSheba Medical Center
- Enrollment300
- Start date2016-11
- ConditionsAcute Lymphoblastic Leukemia, B-precursor · Non-Hodgkin Lymphoma, B-cell
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.